-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 24, the Gansu Provincial Public Resources Trading Center issued the "Notice on Announcement of the Proposed Selection Results of the Ganshan-Shaanxi Alliance's 2021 Drug Centralized and Volume Procurement"
It is worth noting that, unlike most provincial and alliance centralized procurements that do not disclose the price of the selected products, the Ganshan-Shaanxi Alliance announced the packaging prices and preparation prices of the products to be selected
More than 60% of the price of medicines are discounted by half
More than 60% of the price of medicines are discounted by halfOn July 23, the Gansu Provincial Public Resources Trading Center issued the "Gansu-Shaanxi Alliance 2021 Drug Centralized Purchase Documents", which formally approved the documents including aminocaproic acid, ornidazole, isosorbide mononitrate, betahistine, and pyridine.
And after a month of preparations and deliberation, the results of the Gan-Shaan Alliance's centralized procurement and selection have finally surfaced
In addition to troxerutin injection, dyphylline injection (2ml: 0.
However, while more than 60% of the varieties have fallen by 50%, Jilin Jinsheng Pharmaceutical's 25mg/bottle niacin for injection has been eligible for the proposed selection of this variety at a price reduction of one cent
Innovative measures promote pharmaceutical companies to participate in price cuts
Innovative measures promote pharmaceutical companies to participate in price cutsCompared with the previous regional alliances of Beijing-Tianjin Wing "3+N", "six provinces and two regions", and 11 provinces in Shaanxi, the market size of the Gansu-Shaanxi Alliance is obviously not the best, but pharmaceutical companies are willing to reduce prices.
Regarding the agreed purchase volume in the first year, the Ganshan-Shaanxi Alliance made it clear that each group determined 1 company to be selected.
In terms of the selection rules, the Ganshan-Shaanxi Alliance has also innovatively introduced a 1.
Since the “4+7” pilot in 2018, the National Medical Insurance Administration has been actively promoting the reform of centralized drug procurement in conjunction with relevant departments.
Some insiders pointed out that, overall, the full-blown provincial-level procurement and alliance procurement through cross-integration and mutual promotion are in-depth advancement in line with the national top-level set of targets and tasks that should be collected.
Concentrated procurement of drugs in 2021 by the Gansha-Shaanxi Alliance
Concentrated procurement of drugs in 2021 by the Gansha-Shaanxi AllianceCalculation of the reduction in the result of the proposed selection
Calculation of the reduction in the result of the proposed selection